A Study of Simmitinib Versus Chemotherapy for Participants With Advanced Oesophageal Squamous Cell Carcinoma
Clinical trial NCT06656091 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06656091
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2027-01-30
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.